This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 1979.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1979
Title: William A Million: Innovator in Antibiotic Intermediates
Introduction
William A Million is a notable inventor based in Ramsgate, GB. He has made significant contributions to the field of antibiotic research, particularly through his innovative work on aminoglycoside antibiotics. His expertise and dedication have led to the development of valuable pharmaceutical intermediates.
Latest Patents
William A Million holds a patent for "Intermediates for aminoglycoside antibiotics." This patent describes derivatives of kanamycin A, which possess an acyl protecting group on the C-3' and C-6' amino groups. These derivatives are useful intermediates for preparing 1-N-(.omega.-amino-2-hydroxyalkyl) derivatives of kanamycin A. Additionally, the patent covers derivatives of kanamycin B, which also have acyl protecting groups and are useful for similar applications. The invention highlights the potential of these compounds as antibacterial agents.
Career Highlights
William A Million is associated with Pfizer Corporation, a leading pharmaceutical company. His work at Pfizer has allowed him to contribute to the advancement of antibiotic therapies. With a focus on innovative solutions, he has played a crucial role in the development of new medicinal compounds.
Collaborations
Throughout his career, William has collaborated with esteemed colleagues such as Rhona M Plews and Kenneth Richardson. These partnerships have fostered a collaborative environment that enhances research and development efforts in the field of antibiotics.
Conclusion
William A Million's contributions to antibiotic research through his innovative patents and collaborations underscore his importance in the pharmaceutical industry. His work continues to impact the development of effective antibacterial agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
